Rocio G. C.
- Country
- Spain
- Department
- Servicio de Oncología Médica
Research Overview
- Evaluation of Anti-CEACAM5 Antibody-Drug Conjugate M9140 in Patients with Advanced Solid Tumors
- Phase 1b Study of OMTX705 in Patients with Advanced/Metastatic Pancreatic Adenocarcinoma
- Safety and Efficacy of RO7673396 Monotherapy and Combination Therapy in Patients with Advanced RAS-Mutant Solid Tumors
Data & Insights
Has run more than one trial at 215 of 382 partner sites.
Specializations
Gastrointestinal Oncology
The investigator specializes in treating complex metastatic colorectal cancer and advanced gastrointestinal neuroendocrine tumors. Their research encompasses innovative therapeutic approaches for aggressive forms of GI cancers.
- Colorectal Cancer Management
- GEP-NET Treatment Strategies
- Microsatellite Status Assessment
Their expertise extends to treating both well-differentiated and aggressive grade neuroendocrine tumors.
Pancreatic Cancer Research
The investigator focuses on advanced treatment approaches for pancreatic ductal adenocarcinoma, including both metastatic and resected cases. Their work encompasses adjuvant therapy strategies and novel therapeutic combinations.
- Metastatic PDAC Treatment
- Post-Surgical Therapeutic Approaches
- Combined Modality Treatment
The research includes evaluation of innovative therapeutic protocols for various stages of pancreatic cancer.
Precision Medicine Applications
The investigator explores personalized treatment approaches including genetic vaccines and targeted therapies for specific tumor types. Their work involves molecular-based treatment selection and biomarker-driven therapies.
- Immunotherapy Integration
- Targeted Therapeutic Approaches
- Biomarker-Guided Treatment
Research focuses on matching specific tumor characteristics with appropriate therapeutic interventions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.